Clinical Trials Browser

Phase 1 × OTHER × SB939 compound × Clear all

NCT03848754 2022-06-30

Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute